Alveolar macrophage function is impaired following inhalation of berry e-cigarette vapor.

alveolar macrophages e-cigarette exposure infection control intravital microscopy

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: ppublish

Résumé

In the lower respiratory tract, the alveolar spaces are divided from the bloodstream and the external environment by only a few microns of interstitial tissue. Alveolar macrophages (AMs) defend this delicate mucosal surface from invading infections by regularly patrolling the site. AMs have three behavior modalities to achieve this goal: extending cell protrusions to probe and sample surrounding areas, squeezing the whole cell body between alveoli, and patrolling by moving the cell body around each alveolus. In this study, we found Rho GTPase, cell division control protein 42 (CDC42) expression significantly decreased after berry-flavored e-cigarette (e-cig) exposure. This shifted AM behavior from squeezing to probing. Changes in AM behavior led to a reduction in the clearance of inhaled bacteria,

Identifiants

pubmed: 39312670
doi: 10.1073/pnas.2406294121
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2406294121

Subventions

Organisme : Canadian Government | Canadian Institutes of Health Research (CIHR)
ID : 487169

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Amelia Kulle (A)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.

Ziyi Li (Z)

Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.

Ashley Kwak (A)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.

Mathieu Mancini (M)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.
Dahdaleh Institute for Genomic Medicine, Montréal, QC H3A 0G1, Canada.

Daniel Young (D)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB T2N 4N1, Canada.

Daina Zofija Avizonis (DZ)

Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada.

Marc Groleau (M)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.

Carolyn J Baglole (CJ)

Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.
Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montréal, QC H4A 3J1, Canada.

Marcel A Behr (MA)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.

Irah L King (IL)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.
Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
McGill Interdisciplinary Initiative in Infection and Immunity, Montréal, QC H3A 1Y2, Canada.
McGill Centre for Microbiome Research, Montréal, QC H4A 3J1, Canada.

Maziar Divangahi (M)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.
Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montréal, QC H4A 3J1, Canada.

David Langlais (D)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.
Dahdaleh Institute for Genomic Medicine, Montréal, QC H3A 0G1, Canada.
Department of Human Genetics, McGill University, Montréal, QC H3A 0C7, Canada.

Jing Wang (J)

Department of Immunology and Microbiology, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai 20025, China.

Julianna Blagih (J)

Department of Obstetrics and Gynecology, University of Montréal, Montréal, QC H3C 3J7, Canada.

Erika Penz (E)

Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.

Antoine Dufour (A)

Department of Physiology and Pharmacology, University of Calgary, Calgary, AB T2N 4N1, Canada.

Ajitha Thanabalasuriar (A)

Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.
Department of Pharmacology and Therapeutics, McGill University, Montréal, QC H3G 1Y6, Canada.

Classifications MeSH